we have sought the presence of such activating mutations in a series of 100 cases of human breast cancer by polymerase chain reaction amplification and sequence-specific oligonucleotide hybridization , and also by a designed restriction fragment length polymorphism strategy in cases with southern blot evidence of c-erbb-2 amplification .
C0086418
human
C0243036
erbb